Aterian Inc vs ResMed Inc. — how do they compare? Aterian Inc trades at $0.48 (market cap $5.32M), while ResMed Inc. trades at $220 (market cap $32.61B). The key difference: ResMed Inc. is far larger — about 6129.7× Aterian Inc's market cap, and ResMed Inc. pays a 1.17% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.
| ATER | RMD | |
|---|---|---|
Market Cap | $5.32M | $32.61B |
Sector | Consumer Cyclical | Health |
52-Week High | $1.39 | $293.73 |
52-Week Low | $0.36 | $182.82 |
Enterprise Value | $5.90M | $31.97B |
Dividend Yield | — | 1.17% |
Trailing returns across standard periods
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →